- Histologically or cytologically documented, locally advanced or metastatic (i.e., Stage IIIB not eligible for definitive chemoradiotherapy, Stage IV, or recurrent) non-small cell lung cancer (NSCLC) (per the American Joint Committee /AJCC staging system)